Narrative review / 2023
A review reports that incorporating a lacto-ovo-vegetarian diet into IBD therapy achieved a 96% remission rate in newly developed Crohn's disease.
This review describes the rationale for using a plant-based diet (PBD, specifically a lacto-ovo-vegetarian diet) in inflammatory bowel disease (IBD) and reviews the authors' modality in Japan. Infliximab and PBD as first-line therapy for newly developed Crohn's disease (CD) achieved a 96% remission rate and yielded a relapse-free course in 52% of patients. The authors assert that IBD is linked to dietary westernization and recommend PBD as part of IBD therapy.
- Study type
- Narrative review of author studies and literature
- Who was studied
- Patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis)
- What was measured
- Remission rate and relapse-free course
THE PAPER
Incorporation of Plant-Based Diet Surpasses Current Standards in Therapeutic Outcomes in Inflammatory Bowel Disease.
Chiba M, Morita N. Metabolites, 2023.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.